Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.

Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women

DE LEO, V.
LA MARCA, A.
MORGANTE, G.
LANZETTA, D.
SETACCI, C.
PETRAGLIA, F.

January 2001

Raloxifene, a selective estrogen receptor modulator, has beneficial estrogen agonist effects on bone...

Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels

Chiantera, V.
Sarti, C.
Fornaro, F.
Farzati, A.
De Franciscis, P.
Sepe, E.
Borrelli, A.
Colacurci, N.

January 2003

Objective: To compare the long-term effects of oral and transdermal hormone replacement therapy (HRT...

The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women:a randomized controlled trial

Hak, AE
Bak, AAA
Lindemans, J
Planellas, J
Bennink, HJTC
Hofman, A
Grobbee, DE
Witteman, JCM

October 2001

Serum homocysteine levels may be lowered by hormone replacement therapy, but randomized controlled t...

Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.

Karas, C
AKAN, PINAR
Dogan, E
Saygili, U
Posaci, C
Gol, M

February 2006

Objectives: To investigate the effects of conjugated equine estrogen (CEE), CEE plus medroxyprogeste...

What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?

Eli Marcelo Lakryc
Rogério Bonassi Machado
José Maria Soares Jr
Edmund Chada Baracat
César Eduardo Fernandes

OBJECTIVE: To evaluate the influence of estrogen therapy and estrogen-progestin therapy on homocyste...

The effects of raloxifene on serum lipid profiles, C-reactive protein and homocysteine levels in postmenopausal women

Çalişkan, Sezer
ALTUNYURT, SABAHATTİN
Güçlü, Serkan
Turan, Gülizar Arzu
POSACI, CEMAL
Doǧan, Erbil

June 2006

Objective: To investigate the effects of raloxifene on serum lipid profiles and C-reactive protein a...

Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women

ROSSI, Rosario
CAGNACCI, Angelo
MODENA, Maria Grazia
Bursi, F
Veronesi, B

January 2004

Background: C-reactive protein (CRP) represents an independent risk factor for coronary disease and ...

SerumHigh-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy inWomenWith Polycystic Ovary Syndrome: A Prospective, Matched Study

Alexis Papanikolaou
Dimitrios Panidis

October 2016

The study evaluated the effect of 5 hormonal regimes on serum levels of high-sensitivity C-reactive ...

Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen

Modena, Maria Grazia
Bursi, F
Fantini, G
Cagnacci, Angelo
Carbonieri, A
Fortuna, A
Rossi, Rosario

January 2002

C-reactive protein, an acute phase reactant, is a sensitive marker of inflammation. High plasma leve...

The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women

Smith, N.L.
Heckbert, S.R.
Doggen, Catharina Jacoba Maria
Lemaitre, R.N.
Reiner, A.P.
Lumley, T.
Meijers, J.C.M.
Psaty, B.M.
Rosendaal, F.R.

January 2006

Objectives: Clinical trials have demonstrated that oral conjugated equine estrogen (CEE) therapy wit...

Fukaya T. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women. Arterioscler Thromb Vasc Biol 2004;24:571–576. [PubMed: 14699021

Akihiko Wakatsuki
Nobuo Ikenoue
Koichi Shinohara
Kazushi Watanabe
Takao Fukaya

October 2016

Objective—Although oral estrogen replacement therapy (ERT) in postmenopausal women improves endothel...

Effect of different hormone replacement therapies on serum lipid lipoprotein levels and inflammation markers in postmenopausal women [Farkli hormon replasman tedavi şekillerinin postmenopozal kadinlarda serum lipid lipoprotein düzeyleri ve enflamasyon belirteçleri üzerine etkileri]

Akman L.
Ulukuş M.
Duygu H.
Ulukuş M.
Özerkan F.
Akin M.

January 2008

Objective: The aim of this study is to investigate the effects of estrogens, combined estrogen-proge...

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women

Decensi A
Omodei U
Robertson C
Bonanni B
Guerrieri-Gonzaga A
Ramazzotto F
Johansson H
Mora S
Sandri MT
Cazzaniga M
Franchi M
Pecorelli S

January 2002

Background—The increase in C-reactive protein (CRP) during oral conjugated equine estrogen (CEE) may...

Effect of Transdermal 17 Beta-Estradiol and Oral Conjugated Equine Estrogens on Biochemical Parameters of Bone Resorption in Natural Menopause

Reginster, Jean-Yves
Christiansen, C.
Dequinze, B.
Deroisy, Rita
Gaspard, Ulysse
Taquet, A. N.
Franchimont, P.

July 1993

OBJECTIVE: To evaluate and compare the effects or oral and transdermal estrogen replacement therapy ...

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

Valk-de Roo, G.W. de
Stehouwer, C.D.A.
Meijer, P.
Mijatovic, V.
Kluft, C.
Kenemans, P.
Cohen, F.
Watts, S.
Netelenbos, C.

January 1999

Currently raloxifene, a selective estrogen receptor modulator, is being investigated as a potential ...

Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women

DE LEO, V.
LA MARCA, A.
MORGANTE, G.
LANZETTA, D.
SETACCI, C.
PETRAGLIA, F.

January 2001

Raloxifene, a selective estrogen receptor modulator, has beneficial estrogen agonist effects on bone...

Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels

Chiantera, V.
Sarti, C.
Fornaro, F.
Farzati, A.
De Franciscis, P.
Sepe, E.
Borrelli, A.
Colacurci, N.

January 2003

Objective: To compare the long-term effects of oral and transdermal hormone replacement therapy (HRT...

The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women:a randomized controlled trial

Hak, AE
Bak, AAA
Lindemans, J
Planellas, J
Bennink, HJTC
Hofman, A
Grobbee, DE
Witteman, JCM

October 2001

Serum homocysteine levels may be lowered by hormone replacement therapy, but randomized controlled t...

Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.

Karas, C
AKAN, PINAR
Dogan, E
Saygili, U
Posaci, C
Gol, M

February 2006

Objectives: To investigate the effects of conjugated equine estrogen (CEE), CEE plus medroxyprogeste...

What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?

Eli Marcelo Lakryc
Rogério Bonassi Machado
José Maria Soares Jr
Edmund Chada Baracat
César Eduardo Fernandes

OBJECTIVE: To evaluate the influence of estrogen therapy and estrogen-progestin therapy on homocyste...

The effects of raloxifene on serum lipid profiles, C-reactive protein and homocysteine levels in postmenopausal women

Çalişkan, Sezer
ALTUNYURT, SABAHATTİN
Güçlü, Serkan
Turan, Gülizar Arzu
POSACI, CEMAL
Doǧan, Erbil

June 2006

Objective: To investigate the effects of raloxifene on serum lipid profiles and C-reactive protein a...

Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women

ROSSI, Rosario
CAGNACCI, Angelo
MODENA, Maria Grazia
Bursi, F
Veronesi, B

January 2004

Background: C-reactive protein (CRP) represents an independent risk factor for coronary disease and ...

SerumHigh-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy inWomenWith Polycystic Ovary Syndrome: A Prospective, Matched Study

Alexis Papanikolaou
Dimitrios Panidis

October 2016

The study evaluated the effect of 5 hormonal regimes on serum levels of high-sensitivity C-reactive ...

Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen

Modena, Maria Grazia
Bursi, F
Fantini, G
Cagnacci, Angelo
Carbonieri, A
Fortuna, A
Rossi, Rosario

January 2002

C-reactive protein, an acute phase reactant, is a sensitive marker of inflammation. High plasma leve...

The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women

Smith, N.L.
Heckbert, S.R.
Doggen, Catharina Jacoba Maria
Lemaitre, R.N.
Reiner, A.P.
Lumley, T.
Meijers, J.C.M.
Psaty, B.M.
Rosendaal, F.R.

January 2006

Objectives: Clinical trials have demonstrated that oral conjugated equine estrogen (CEE) therapy wit...

Fukaya T. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women. Arterioscler Thromb Vasc Biol 2004;24:571–576. [PubMed: 14699021

Akihiko Wakatsuki
Nobuo Ikenoue
Koichi Shinohara
Kazushi Watanabe
Takao Fukaya

October 2016

Objective—Although oral estrogen replacement therapy (ERT) in postmenopausal women improves endothel...

Effect of different hormone replacement therapies on serum lipid lipoprotein levels and inflammation markers in postmenopausal women [Farkli hormon replasman tedavi şekillerinin postmenopozal kadinlarda serum lipid lipoprotein düzeyleri ve enflamasyon belirteçleri üzerine etkileri]

Akman L.
Ulukuş M.
Duygu H.
Ulukuş M.
Özerkan F.
Akin M.

January 2008

Objective: The aim of this study is to investigate the effects of estrogens, combined estrogen-proge...

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women

Decensi A
Omodei U
Robertson C
Bonanni B
Guerrieri-Gonzaga A
Ramazzotto F
Johansson H
Mora S
Sandri MT
Cazzaniga M
Franchi M
Pecorelli S

January 2002

Background—The increase in C-reactive protein (CRP) during oral conjugated equine estrogen (CEE) may...

Effect of Transdermal 17 Beta-Estradiol and Oral Conjugated Equine Estrogens on Biochemical Parameters of Bone Resorption in Natural Menopause

Reginster, Jean-Yves
Christiansen, C.
Dequinze, B.
Deroisy, Rita
Gaspard, Ulysse
Taquet, A. N.
Franchimont, P.

July 1993

OBJECTIVE: To evaluate and compare the effects or oral and transdermal estrogen replacement therapy ...

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

Valk-de Roo, G.W. de
Stehouwer, C.D.A.
Meijer, P.
Mijatovic, V.
Kluft, C.
Kenemans, P.
Cohen, F.
Watts, S.
Netelenbos, C.

January 1999

Currently raloxifene, a selective estrogen receptor modulator, is being investigated as a potential ...

Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women

DE LEO, V.
LA MARCA, A.
MORGANTE, G.
LANZETTA, D.
SETACCI, C.
PETRAGLIA, F.

January 2001

Raloxifene, a selective estrogen receptor modulator, has beneficial estrogen agonist effects on bone...

Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels

Chiantera, V.
Sarti, C.
Fornaro, F.
Farzati, A.
De Franciscis, P.
Sepe, E.
Borrelli, A.
Colacurci, N.

January 2003

Objective: To compare the long-term effects of oral and transdermal hormone replacement therapy (HRT...

The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women:a randomized controlled trial

Hak, AE
Bak, AAA
Lindemans, J
Planellas, J
Bennink, HJTC
Hofman, A
Grobbee, DE
Witteman, JCM

October 2001

Serum homocysteine levels may be lowered by hormone replacement therapy, but randomized controlled t...

Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.

Abstract

Extracted data

Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.

Abstract

Extracted data

Related items

Related items